TREATMENTS DURING PREECLAMPSIA AND PREGNANCY

Authors

  • Eshbayev Erkin Abduxalimovich.,Ro’ziyev M.I Tashkent Medical Academy Author

Keywords:

Preeclampsia, diseases, risk factors, effects, patients, life, nutrints, mothers

Abstract

Toxemia is a difficult condition that can happen during pregnancy, described by hypertension and indications of harm to other organ frameworks, most frequently the liver and kidneys. It ordinarily happens following 20 weeks of pregnancy and can prompt serious inconveniences for both the mother and the child while perhaps not appropriately made due. In this article, we will investigate the different medicines accessible for toxemia and the ramifications for pregnancy.

References

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237-e260.

Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008 Feb;26(2):295-302.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019 May;15(5):275-289.

Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986 Nov;155(5):1011-6.

Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and Current Clinical Management of Preeclampsia. Curr Hypertens Rep. 2017 Aug;19(8):61.

Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines. Clin J Am Soc Nephrol. 2016 Jun 06;11(6):1102-1113.

Published

2024-02-05